Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Safety Evaluation of Human Rabies Immune Globulin 300 IU/mL in Children

NCT05382650 is registered in ClinicalTrials.gov with The Methodist Hospital Research Institute as lead sponsor.

NCT NCT05382650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Safety Evaluation of Human Rabies Immune Globulin 300 IU/mL in Children
Lead sponsor
The Methodist Hospital Research Institute
Phase
Observational
Overall status
Terminated
Start date
February 22, 2023
Completion date
October 15, 2025
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pediatrics, rabies, rabies human, rabies virus infection